The North America multiple sclerosis therapeutics market is expected to reach US$ 15,269.74 million by 2027 from US$ 9,144.98 million in 2019; it is estimated to grow at a CAGR of 6.8% from 2020 to 2027. Get a sample PDF of the report – https://www.businessmarketinsights.com/sample/TIPRE00022633 North America multiple sclerosis therapeutics market Overview The growth of the...